Microsamplify Podcast | Neoteryx

Mitra® is an exempt medical device in the US, CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, and registered with Health Canada. It is intended as a specimen collector and for the storage and transport of biological fluids. Use of the device with blood for diagnostic applications is limited to certain countries and, in the US, to research and non-diagnostic uses. Neoteryx Products are not marketed in the U.S for clinical diagnostic uses. In other countries, Neoteryx Products may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

Copyright © 2020 Neoteryx, LLC. All rights reserved.

Christa Nuber

All stories by Christa

microsampling in toxicology: biomarkers of drugs & alcohol: Dr. Christophe Stove & Dr. Katleen Van Uytfanghe

microsampling in proteomics, precision medicine: Jennifer Van Eyk, PhD

microsampling for patients on therapeutic drugs: Florian Lemaitre, PharmD, PhD

remote blood microsampling for health & wellness: Caroline Priese

microsampling for neurodegenerative diseases & CNS drugs: Dr. Michele Protti

a COVID-19 assay that analyzes serum & microsamples: LGC's Mike Wright

supporting doctors with lab services for telehealth: Dr. Cliff Morris

microsampling in the bioanalytical laboratory: Dr. Remco Koster

lab-compatible microsampling: it’s value in a coronavirus pandemic world

Drop us a line

Neoteryx, LLC